Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $20.4000 (-1.69%) ($20.0000 - $20.8000) on Mon. Mar. 27, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.08% (three month average) | RSI | 65 | Latest Price | $20.4000(-1.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.8% a day on average for past five trading days. | Weekly Trend | ATRA advances 3.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(50%) IWO(48%) ARKK(46%) | Factors Impacting ATRA price | ATRA will decline at least -2.54% in a week (0% probabilities). VIXM(-15%) TLT(-13%) UUP(-10%) UNG(-3%) IPO(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.54% (StdDev 5.08%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
5 Day Moving Average | $20.77(-1.78%) | 10 Day Moving Average | $20.32(0.39%) | 20 Day Moving Average | $19.24(6.03%) | To recent high | -10.1% | To recent low | 61.3% | Market Cap | $1.516b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |